Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study

The benefits of remdesivir treatment, with or without co-administration of antibiotics such as azithromycin, are uncertain in COVID-19 pneumonia. The aim of this retrospective single-center study was to assess the effects of remdesivir, with or without azithromycin, on hospital mortality, intensive...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Andrea Ticinesi, Domenico Tuttolomondo, Antonio Nouvenne, Alberto Parise, Nicoletta Cerundolo, Beatrice Prati, Ilaria Zanichelli, Angela Guerra, Nicola Gaibazzi, Tiziana Meschi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-07-01
Saila:	Antibiotics
Gaiak:	SARS-CoV-2 antiviral antibiotic azithromycin remdesivir
Sarrera elektronikoa:	https://www.mdpi.com/2079-6382/11/7/941
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!